Brachytherapy: Increased Use in Patients With Intermediate- and High-Risk Prostate Cancers.

Abstract

BACKGROUND\nBrachytherapy is a well-established and effective primary treatment modality for low- and favorable intermediate-risk prostate cancers. Although the benefits of brachytherapy in unfavorable intermediate- and high-risk prostate cancers have not been as clear, research suggests that brachytherapy boost may improve biochemical progression-free survival in these patients.\n\n\nOBJECTIVES\nThis article aims to discuss evidence for the revival of brachytherapy use in unfavorable intermediate- and high-risk prostate cancers and specific nursing implications in the management of these patients.\n\n\nMETHODS\nThe literature on brachytherapy and its use to treat localized prostate cancers was reviewed.\n\n\nFINDINGS\nNurses should be knowledgeable about the indications for brachytherapy, patient eligibility, anticipated side effects, and symptom management.